SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
34,200
+350 (1.03%)
Aug 3, 2026, 3:30 PM KST

SK bioscience Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
86,717105,553312,702127,026225,28798,028
Short-Term Investments
176,877380,848233,542275,3005,300-0
Trading Asset Securities
626,563419,900611,864871,8161,250,2181,547,635
Cash & Short-Term Investments
890,157906,3011,158,1081,274,1411,480,8061,645,663
Cash Growth
-24.79%-21.74%-9.11%-13.96%-10.02%-
Accounts Receivable
143,175122,00894,46212,92839,58538,006
Other Receivables
10,17310,93593,9349,41450,07610,129
Receivables
153,567132,943188,39622,34289,66148,135
Inventory
188,705189,203211,12680,649187,406135,046
Prepaid Expenses
9,5735,7985,7481,6131,6491,407
Other Current Assets
11,89111,88013,2954,22424,1737,554
Total Current Assets
1,253,8931,246,1251,576,6731,382,9691,783,6941,837,804
Property, Plant & Equipment
1,144,5501,130,387982,607315,923293,057220,983
Long-Term Investments
207,635234,81122,35742,7291,50021,610
Goodwill
56,81555,25357,436---
Other Intangible Assets
69,81271,83256,08414,1786,2993,973
Long-Term Deferred Tax Assets
136,864124,701108,13559,21921,37010,242
Long-Term Deferred Charges
96,80566,87611,0278,28111,88213,088
Other Long-Term Assets
23,35725,75829,27729,14024,1292,422
Total Assets
2,991,8862,955,7442,843,5961,852,4392,141,9312,110,123

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
34,55135,28717,8183,37011,05363,812
Accrued Expenses
62,79352,63954,29819,71630,24226,322
Short-Term Debt
----45,55011,671
Current Portion of Long-Term Debt
----38,00847,978
Current Portion of Leases
2,4463,7536,9578,13712,2352,309
Current Income Taxes Payable
1,4151,3806,994-20,216101,486
Other Current Liabilities
209,076233,179224,523104,397222,733206,374
Total Current Liabilities
310,282326,238310,589135,620380,037459,952
Long-Term Debt
534,206464,738383,331--35,503
Long-Term Leases
1,3471,4972,52612,43617,5438,775
Pension & Post-Retirement Benefits
-----4,246
Long-Term Deferred Tax Liabilities
64,67464,03671,960---
Other Long-Term Liabilities
57,77461,78052,737527.842,649335.24
Total Liabilities
968,284918,289821,144148,584400,229508,811

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
39,22839,21739,17438,41438,39238,250
Additional Paid-In Capital
1,236,4961,236,2721,235,3761,160,4561,160,0081,157,064
Retained Earnings
411,934445,262499,757549,421533,378405,305
Comprehensive Income & Other
83,15568,04928,258-44,4359,924692.92
Total Common Equity
1,770,8131,788,8001,802,5651,703,8551,741,7021,601,312
Minority Interest
252,789248,654219,887---
Shareholders' Equity
2,023,6032,037,4542,022,4521,703,8551,741,7021,601,312
Total Liabilities & Equity
2,991,8862,955,7442,843,5961,852,4392,141,9312,110,123

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
538,000469,988392,81420,574113,336106,236
Net Cash (Debt)
352,157436,313765,2941,253,5681,367,4691,539,428
Net Cash Growth
-54.87%-42.99%-38.95%-8.33%-11.17%-
Net Cash Per Share
4492.475567.649912.9616277.2017754.3920850.38
Filing Date Shares Outstanding
78.4678.4378.3576.8376.7876.5
Total Common Shares Outstanding
78.4678.4378.3576.8376.7876.5
Working Capital
943,611919,8871,266,0831,247,3501,403,6571,377,852
Book Value Per Share
22570.6222806.2323007.3722177.6022683.1220932.18
Tangible Book Value
1,644,1861,661,7151,689,0451,689,6781,735,4031,597,339
Tangible Book Value Per Share
20956.6521185.9721558.4321993.0622601.0920880.24
Land
92,19091,37771,30745,28045,2709,949
Buildings
707,111426,843425,887124,315127,741119,990
Machinery
165,083167,795174,92255,87953,14151,037
Construction In Progress
106,727372,934231,27465,63833,15325,884